Xiao Run Chang
Direktor/Vorstandsmitglied bei Beijing Hongcheng Liye Technology Co., Ltd.
Aktive Positionen von Xiao Run Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Beijing Hongcheng Liye Technology Co., Ltd.
Beijing Hongcheng Liye Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing Hongcheng Liye Technology Co., Ltd. provides integrated services including technology platform development, operation, and maintenance. Its services include online higher education, off-campus learning center, adult education, information technology training, and corporate training. The company was founded on May 19, 2003 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 18.12.2016 | - |
Independent Dir/Board Member | 18.12.2016 | - | |
XinYu Pharmaceutical Co., Ltd.
XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Direktor/Vorstandsmitglied | 01.09.2015 | - |
Independent Dir/Board Member | 01.09.2015 | - | |
Guodu Securities Co., Ltd.
Guodu Securities Co., Ltd. Investment Banks/BrokersFinance Guodu Securities Co., Ltd. engages in the provision of capital market services. It offers securities brokerage, securities investment consulting, financial advisors related to trading and securities investment activities, securities underwriting and sponsorship, securities proprietary trading, securities asset management and securities investment fund agency sales. The firm also involves in the intermediary introduction business for future companies; margin financing and securities lending business; agency sales of financial products business; and public offering of securities investment fund management business. The company was founded on December 28, 2001 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 25.12.2020 | - |
Independent Dir/Board Member | 25.12.2020 | - |
Karriereverlauf von Xiao Run Chang
Ehemalige bekannte Positionen von Xiao Run Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
WESTERN SECURITIES CO.,LTD. | Direktor/Vorstandsmitglied | 01.11.2014 | - |
Independent Dir/Board Member | 01.11.2014 | - |
Ausbildung von Xiao Run Chang
Renmin University of China | Doctorate Degree |
Statistik
International
China | 6 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Doctorate Degree | 1 |
Sektoral
Finance | 3 |
Technology Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
WESTERN SECURITIES CO.,LTD. | Finance |
Finance |
Private Unternehmen | 2 |
---|---|
Beijing Hongcheng Liye Technology Co., Ltd.
Beijing Hongcheng Liye Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing Hongcheng Liye Technology Co., Ltd. provides integrated services including technology platform development, operation, and maintenance. Its services include online higher education, off-campus learning center, adult education, information technology training, and corporate training. The company was founded on May 19, 2003 and is headquartered in Beijing, China. | Technology Services |
XinYu Pharmaceutical Co., Ltd.
XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Börse
- Insiders
- Xiao Run Chang
- Erfahrung